Human airway epithelium controls Pseudomonas aeruginosa infection via inducible nitric oxide synthase

Front Immunol. 2024 Dec 3:15:1508727. doi: 10.3389/fimmu.2024.1508727. eCollection 2024.

Abstract

Introduction: Airway epithelial cells play a central role in the innate immune response to invading bacteria, yet adequate human infection models are lacking.

Methods: We utilized mucociliary-differentiated human airway organoids with direct access to the apical side of epithelial cells to model the initial phase of Pseudomonas aeruginosa respiratory tract infection.

Results: Immunofluorescence of infected organoids revealed that Pseudomonas aeruginosa invades the epithelial barrier and subsequently proliferates within the epithelial space. RNA sequencing analysis demonstrated that Pseudomonas infection stimulated innate antimicrobial immune responses, but specifically enhanced the expression of genes of the nitric oxide metabolic pathway. We demonstrated that activation of inducible nitric oxide synthase (iNOS) in airway organoids exposed bacteria to nitrosative stress, effectively inhibiting intra-epithelial pathogen proliferation. Pharmacological inhibition of iNOS resulted in expansion of bacterial proliferation whereas a NO producing drug reduced bacterial numbers. iNOS expression was mainly localized to ciliated epithelial cells of infected airway organoids, which was confirmed in primary human lung tissue during Pseudomonas pneumonia.

Discussion: Our findings highlight the critical role of epithelial-derived iNOS in host defence against Pseudomonas aeruginosa infection. Furthermore, we describe a human tissue model that accurately mimics the airway epithelium, providing a valuable framework for systemically studying host-pathogen interactions in respiratory infections.

Keywords: Pseudomonas aeruginosa; airway epithelia; airway organoids; iNOS; innate immunity.

MeSH terms

  • Epithelial Cells / immunology
  • Epithelial Cells / metabolism
  • Epithelial Cells / microbiology
  • Host-Pathogen Interactions / immunology
  • Humans
  • Immunity, Innate
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type II* / genetics
  • Nitric Oxide Synthase Type II* / metabolism
  • Organoids* / microbiology
  • Pseudomonas Infections* / immunology
  • Pseudomonas Infections* / microbiology
  • Pseudomonas aeruginosa* / immunology
  • Pseudomonas aeruginosa* / physiology
  • Respiratory Mucosa* / immunology
  • Respiratory Mucosa* / metabolism
  • Respiratory Mucosa* / microbiology

Substances

  • Nitric Oxide Synthase Type II
  • NOS2 protein, human
  • Nitric Oxide

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This research was funded in whole or in part by the Austrian Science Fund (FWF, DOC 82 doc.fund; doi: 10.55776/DOC82). For open access purposes, the author has applied a CC BY public copyright license to any author accepted manuscript version arising from this submission. Furthermore, this work was supported by the Medical University of Innsbruck (project CONNECT) and by the European Research Council (project EPIC grant agreement no. 786895 to ZT). Financial support by the Christian Doppler Society (Laboratory of Iron Metabolism and Anemia Research) and the “Verein zur Förderung von Forschung und Weiterbildung in Infektiologie und Immunologie an der Medizinischen Universität Innsbruck” is gratefully acknowledged.